Dividends Calendar   Earnings Calendar
NTLA

NTLA  |  Intellia Therapeutics Inc

Intellia Therapeutics Inc

Historical Data

Date Price Open High Low Vol Change ER
Nov 19 129.48 133.78
134.90
129.00
600.66K -4.02%
Nov 18 134.90 134.74
137.84
133.25
541.75K 0.37%
Nov 17 134.40 136.98
138.35
133.00
593.56K -2.26%
Nov 16 137.51 132.82
137.91
130.54
398.52K 2.97%
Nov 15 133.54 132.56
133.58
129.64
665.42K 0.99%
Nov 12 132.23 131.46
132.93
127.89
494.21K 1.33%
Nov 11 130.50 128.25
132.44
127.78
468.56K 2.93%
Nov 10 126.78 137.30
139.65
126.53
911.63K -8.37%
Nov 9 138.36 137.72
141.26
134.13
720.52K 1.68%
Nov 8 136.07 135.48
143.92
135.45
614.10K 0.44%
Nov 5 135.48 132.42
138.46
130.77
547.90K 1.15%
Nov 4 133.94 135.00
138.47
132.59
651.89K -1.45%
Nov 3 135.91 135.42
137.99
133.22
544.81K 0.17%
Nov 2 135.68 135.91
139.89
133.14
528.37K -0.61%
Nov 1 136.51 134.19
138.19
133.68
525.50K 2.65%
Oct 29 132.98 131.34
135.36
130.68
672.89K -2.3%
Oct 28 136.11 131.50
136.23
130.61
484.86K 5.02%
Oct 27 129.60 132.63
133.00
129.35
631.97K -1.82%
Oct 26 132.00 133.77
135.50
130.94
356.35K -1.16%
Oct 25 133.55 131.71
136.50
130.61
689.97K 1.54%
Oct 22 131.53 133.64
135.14
129.50
450.18K -2%

Intellia Therapeutics Inc was founded in 2014 (7 years in total.)
And they have a total of 104 employees.



Jump to (Finance sites)

Research 


If you are looking for News & events, Press Release, they are available on their Investors Relations site.


Consensus
BUY 25
HOLD 75
SELL 0

Their Official Profiles 

Wikipedia Twitter LinkedIn Instagram

Peers / Similar stocks 

xlv 

Other stocks 

ibm  tgt  aap  sig  pdco  azo  tvpt  low  afsi  amg  cgc  docu 

Support this project

If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
More features coming soon :)

Social Media 




Recommended Books

The Intelligent Investor
Buy on Amazon

Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

The best book on investing ever written.
-- Warren Buffet